Skip to main content
Contact Us
Subscribe
E-Edition
52°
Site search
Search
Menu
Open user controls
Log In Using Your Account
Log In
Don't have an account?
Sign Up Today
My Account
Dashboard
Profile
Saved items
Logout
Home
About Us
Contact Us
Advertise
Terms and Conditions
Privacy Policy
Home Delivery
Subscription Services
Place an Ad
Promote Your Event
Local Weather
News
Sports
Entertainment
Obits
Multimedia
Photo Galleries
Videos
e-Edition
Classifieds
Real Estate
Property For Rent
Cars & Vehicles
Jobs
Items For Sale
Pets
Auctions, Estate & Garage Sales
Services
Community
Personals
Place An Ad
Subscribe
Best of 2023
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Biomea Fusion Inc
(NQ:
BMEA
)
41.80
UNCHANGED
Streaming Delayed Price
Updated: 4:00 PM EDT, Jun 8, 2023
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
0
Open
-
Bid (Size)
41.87 (1)
Ask (Size)
44.00 (2)
Prev. Close
41.80
Today's Range
41.80 - 41.80
52wk Range
6.040 - 43.69
Shares Outstanding
N/A
Dividend Yield
N/A
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
Analyst Ratings for Biomea Fusion
May 18, 2023
Via
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For May 12, 2023
May 12, 2023
Via
Benzinga
Performance
YTD
+392.92%
+392.92%
1 Month
+23.89%
+23.89%
3 Month
+184.35%
+184.35%
6 Month
+563.49%
+563.49%
1 Year
+464.10%
+464.10%
More News
Read More
Recap: Biomea Fusion Q1 Earnings
May 02, 2023
Via
Benzinga
Biomea Fusion Reports First Quarter 2023 Financial Results and Corporate Highlights
May 02, 2023
From
Biomea Fusion, Inc.
Via
GlobeNewswire
Analyst Ratings for Biomea Fusion
April 19, 2023
Via
Benzinga
Biomea Fusion Announces FDA Clearance of Investigational New Drug (IND) Application for Covalent FLT3 Inhibitor BMF-500 in Relapsed or Refractory Acute Leukemia
May 01, 2023
From
Biomea Fusion, Inc.
Via
GlobeNewswire
Biomea Fusion to Present Late Breaking Data from Ongoing Phase II Trial, COVALENT-111, Evaluating BMF-219 in Patients with Type 2 Diabetes, at the ADA 83rd Scientific Sessions 2023 in June
April 19, 2023
From
Biomea Fusion, Inc.
Via
GlobeNewswire
Biomea Fusion To Present Two Preclinical Posters at the 114th AACR Annual Meeting
April 13, 2023
From
Biomea Fusion, Inc.
Via
GlobeNewswire
Why Biomea Fusion Stock Crushed It This Week
March 30, 2023
Via
The Motley Fool
Where Biomea Fusion Stands With Analysts
March 28, 2023
Via
Benzinga
Biomea Fusion Announces Closing of Upsized Public Offering and Full Exercise of the Underwriters’ Option to Purchase Additional Shares
April 13, 2023
From
Biomea Fusion, Inc.
Via
GlobeNewswire
These 5 High-Growth Small-Cap Stocks Surged More Than 100% In Q1: What's Next?
April 05, 2023
Via
Benzinga
$12M Bet On This Healthcare Stock? Check Out These 3 Stocks Insiders Are Buying
April 04, 2023
Via
Benzinga
Biomea Fusion Announces Pricing of Upsized Public Offering of Common Stock
March 29, 2023
From
Biomea Fusion, Inc.
Via
GlobeNewswire
Is Cathie Wood Giving Up on Xpeng (XPEV) Stock?
March 29, 2023
Via
InvestorPlace
What's Going On With Biomea Fusion Stock?
March 29, 2023
Via
Benzinga
Dear SBNY Stock Fans, Mark Your Calendars for April 5
March 29, 2023
Via
InvestorPlace
BMEA Stock: Biomea Fusion Pops on Public Offering News
March 29, 2023
Via
InvestorPlace
Biomea Fusion Announces Proposed Public Offering of Common Stock
March 29, 2023
From
Biomea Fusion, Inc.
Via
GlobeNewswire
Biomea Fusion Reports Fourth Quarter and Full Year 2022 Financial Results and Corporate Highlights
March 28, 2023
From
Biomea Fusion, Inc.
Via
GlobeNewswire
Nasdaq Dips 90 Points; Walgreens Posts Upbeat Q2 Results
March 28, 2023
Via
Benzinga
12 Health Care Stocks Moving In Tuesday's Intraday Session
March 28, 2023
Via
Benzinga
Why Alibaba Shares Are Trading Higher By Over 8%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
March 28, 2023
Via
Benzinga
Stocks Mixed After Upbeat Consumer Confidence Data
March 28, 2023
Via
Talk Markets
Dow Rises 50 Points; Harmony Biosciences Shares Plunge
March 28, 2023
Via
Benzinga
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.